ARCHIVES

FDA Told To Drop Guidelines, But Remains Unmoved On New Drug Delays

This article is from The Cancer Letter archive.

Vol. 01 No. 49 | December 5, 1975

Download PDF Visit The Full Archive

Related Articles

AACR Using Its Clout To Urge Higher NCI Budget

May 24, 1991

Six Grants Awarded, Five More On Way For Elderly Research

May 4, 1984

Tamoxifen Trial may EB Funded In Part With CCOP Money

March 22, 1991

DRG Executives Names By DeVita as Director Of DEA; Other Sections Reportedly Made, Not Yet Approved

July 31, 1981

Hawaii Epidemiology Studies Offer Opportunities For Major Impact On Cancer Incidence, Survival

January 4, 1985

FDA Approves Inlyta Pill For Renal Cell Carcinoma

January 27, 2012